DK1240823T3 - N-calciumkanal-knockout-dyr - Google Patents
N-calciumkanal-knockout-dyrInfo
- Publication number
- DK1240823T3 DK1240823T3 DK00970097T DK00970097T DK1240823T3 DK 1240823 T3 DK1240823 T3 DK 1240823T3 DK 00970097 T DK00970097 T DK 00970097T DK 00970097 T DK00970097 T DK 00970097T DK 1240823 T3 DK1240823 T3 DK 1240823T3
- Authority
- DK
- Denmark
- Prior art keywords
- calcium channel
- substances
- disrupted
- type calcium
- new
- Prior art date
Links
- 241001465754 Metazoa Species 0.000 title abstract 2
- 108091006146 Channels Proteins 0.000 title 1
- 229910052791 calcium Inorganic materials 0.000 title 1
- 239000011575 calcium Substances 0.000 title 1
- 238000000034 method Methods 0.000 abstract 5
- 239000000126 substance Substances 0.000 abstract 4
- 102000004129 N-Type Calcium Channels Human genes 0.000 abstract 3
- 108090000699 N-Type Calcium Channels Proteins 0.000 abstract 3
- 108090000623 proteins and genes Proteins 0.000 abstract 3
- 108090000312 Calcium Channels Proteins 0.000 abstract 2
- 102000003922 Calcium Channels Human genes 0.000 abstract 2
- 230000002950 deficient Effects 0.000 abstract 2
- 239000003814 drug Substances 0.000 abstract 2
- 208000001953 Hypotension Diseases 0.000 abstract 1
- 230000000202 analgesic effect Effects 0.000 abstract 1
- 239000002220 antihypertensive agent Substances 0.000 abstract 1
- 239000008280 blood Substances 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 208000021822 hypotensive Diseases 0.000 abstract 1
- 230000001077 hypotensive effect Effects 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 230000000144 pharmacologic effect Effects 0.000 abstract 1
- 238000012216 screening Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
- A01K67/027—New or modified breeds of vertebrates
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
- A01K67/027—New or modified breeds of vertebrates
- A01K67/0275—Genetically modified vertebrates, e.g. transgenic
- A01K67/0276—Knock-out vertebrates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/07—Animals genetically altered by homologous recombination
- A01K2217/075—Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2227/00—Animals characterised by species
- A01K2227/10—Mammal
- A01K2227/105—Murine
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2267/00—Animals characterised by purpose
- A01K2267/03—Animal model, e.g. for test or diseases
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Environmental Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biotechnology (AREA)
- Diabetes (AREA)
- Neurosurgery (AREA)
- Biochemistry (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Neurology (AREA)
- Biodiversity & Conservation Biology (AREA)
- Molecular Biology (AREA)
- Animal Husbandry (AREA)
- Biophysics (AREA)
- Pain & Pain Management (AREA)
- Physics & Mathematics (AREA)
- Toxicology (AREA)
- Immunology (AREA)
- Cell Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Obesity (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Cardiology (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP30380999 | 1999-10-26 | ||
JP2000037839 | 2000-02-16 | ||
JP2000261979 | 2000-08-31 | ||
PCT/JP2000/007503 WO2001030137A1 (fr) | 1999-10-26 | 2000-10-26 | Animal knockout a canal n-calcium |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1240823T3 true DK1240823T3 (da) | 2008-12-08 |
Family
ID=27338631
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK00970097T DK1240823T3 (da) | 1999-10-26 | 2000-10-26 | N-calciumkanal-knockout-dyr |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP1240823B1 (da) |
JP (1) | JP2007105046A (da) |
KR (1) | KR100770550B1 (da) |
AT (1) | ATE405156T1 (da) |
DE (1) | DE60040016D1 (da) |
DK (1) | DK1240823T3 (da) |
ES (1) | ES2312365T3 (da) |
WO (1) | WO2001030137A1 (da) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020133840A1 (en) * | 2000-12-11 | 2002-09-19 | Brennan Thomas J. | Transgenic mice containing disruptions in genes encoding A2D2 calcium ion channel subunit proteins |
US20030180712A1 (en) * | 2002-03-20 | 2003-09-25 | Biostratum Ab | Inhibition of the beta3 subunit of L-type Ca2+ channels |
US7713535B2 (en) | 2003-12-08 | 2010-05-11 | Idera Pharmaceuticals, Inc. | Modulation of immunostimulatory properties by small oligonucleotide-based compounds |
US7470674B2 (en) | 2005-11-07 | 2008-12-30 | Idera Pharmaceuticals, Inc. | Immunostimulatory properties of oligonucleotide-based compounds comprising modified immunostimulatory dinucleotides |
US9574176B2 (en) | 2012-10-31 | 2017-02-21 | Eisai R&D Management Co., Ltd. | Neural stem cell having increased passage ability, method for manufacturing neural stem cell having said increased passage abiility, and method for culturing neural stem cells for increasing passage ability of neural stem cells |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5677288A (en) * | 1991-05-15 | 1997-10-14 | Cypros Pharmaceutical Corporation | Use of aminoglycosides to protect against excitotoxic neuron damage |
EP0992585B1 (en) * | 1991-08-15 | 2005-01-12 | Merck & Co., Inc. | Human calcium channel compositions and methods |
WO1999046383A1 (en) * | 1998-03-13 | 1999-09-16 | Brown University Research Foundation | Human n-type calcium channel isoform and uses thereof |
-
2000
- 2000-10-26 EP EP00970097A patent/EP1240823B1/en not_active Expired - Lifetime
- 2000-10-26 AT AT00970097T patent/ATE405156T1/de not_active IP Right Cessation
- 2000-10-26 ES ES00970097T patent/ES2312365T3/es not_active Expired - Lifetime
- 2000-10-26 DE DE60040016T patent/DE60040016D1/de not_active Expired - Lifetime
- 2000-10-26 DK DK00970097T patent/DK1240823T3/da active
- 2000-10-26 KR KR1020027005389A patent/KR100770550B1/ko not_active IP Right Cessation
- 2000-10-26 WO PCT/JP2000/007503 patent/WO2001030137A1/ja active IP Right Grant
-
2006
- 2006-10-31 JP JP2006296517A patent/JP2007105046A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
WO2001030137A1 (fr) | 2001-05-03 |
EP1240823B1 (en) | 2008-08-20 |
ES2312365T3 (es) | 2009-03-01 |
KR100770550B1 (ko) | 2007-10-26 |
DE60040016D1 (de) | 2008-10-02 |
KR20030022761A (ko) | 2003-03-17 |
JP2007105046A (ja) | 2007-04-26 |
ATE405156T1 (de) | 2008-09-15 |
EP1240823A4 (en) | 2003-05-02 |
EP1240823A1 (en) | 2002-09-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1168922T3 (da) | Biologisk sammensætning og fremgangsmåde til at öge planters vækstrate og sundhed, samt til at frembringe sygdomsresistente planter | |
FI963101A0 (fi) | Anti-TNF-vasta-aineiden käyttö lääkkeenä sellaisten sairauksien hoitoon, joissa seerumin interleukiini-6-taso on kohonnut | |
DK1263729T3 (da) | Cykliske azaforbindelser til anvendelse til behandling af serotoninrealterede sygdomme | |
IT1269989B (it) | Antagonisti recettoriali di il-1 ad aumentata attivita' inibitoria | |
WO2001005763A3 (en) | Compounds with activity on muscarinic receptors | |
NO20054959L (no) | Fremgangsmater for behandling av interleukin-6 relaterte sykdommer | |
EA200600868A1 (ru) | Гидрогенолиз сахарного сырья | |
NO20061737L (no) | Aminosubstituerte erylamino B2 adrenergiske receptoragonister | |
ATE408402T1 (de) | Stickstoffmonoxid-donoren zum induzieren von neurogenese | |
DK1240823T3 (da) | N-calciumkanal-knockout-dyr | |
EA199900633A1 (ru) | Способы терапевтического введения анти-cd40l соединений | |
TR199900548A3 (tr) | Düsük kesme kuvvetli taneleme kullanilarak dozaj birimlerinin yapimi. | |
HUP0100171A2 (hu) | Endotelin-receptor-antagonisták alkalmazása elhízás leküzdésére szolgáló gyógyszerkészítmények előállítására | |
AR004093A1 (es) | El uso de una proteina derivada de una quimioquina de mamifero y un medicamento util para movilizar celulas tronco hematopoyeticas. | |
IT8919050A0 (it) | Procedimento per la introduzione di dna esogeno nelle cellule somatiche e germinali di animali. | |
ITRM20030596A1 (it) | Uso di inibitori della pentraxina lunga ptx3, per la preparazione di un medicamento per la prevenzione e cura di patologie che rispondono all'inibizione dell'attivita' biologica di detta ptx3. | |
ITTO20030404A1 (it) | Composizione per il ripristino dell'ecosistema vaginale | |
MY142646A (en) | Chemokine receptor antagonists and methods of use therefor | |
ATE300311T1 (de) | Vorbereitung eines medikaments zur behandlung von refluxösophagitis | |
FR2856555B1 (fr) | Dispositif utilisable pour la culture de moules et procede de cultures et de recolte de moules utilisant ce dispositif | |
AR026768A1 (es) | Moleculas similares a antagonistas de receptores de interleukin-1 y usos de las mismas | |
Dawes | Macroalgae of the Tampa Bay estuarine system. | |
Tsuzaki et al. | Interleukin-1 beta stimulates expression of Cox II and MMP I in human tendon epitenon cells | |
RU2002133911A (ru) | Способ кормления сельскохозяйственных животных | |
RU2001129061A (ru) | Способ регионарной лимфостимуляции и обезболивания при лимфедеме нижних конечностей |